Web Focus

The development of RNAi as a therapeutic strategy


Top

2008

Top
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA

Shyh-Dar Li, Sumio Chono and Leaf Huang

Molecular Therapy 16: 942-946; doi:10.1038/mt.2008.51

Top
AAV Vector-mediated RNAi of Mutant Huntingtin Expression Is Neuroprotective in a Novel Genetic Rat Model of Huntington's Disease

Nicholas R Franich, Helen L Fitzsimons, Dahna M Fong, Matthias Klugmann, Matthew J During and Deborah Young

Molecular Therapy 16: 947-956; doi:10.1038/mt.2008.50

Top
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition

Kazutaka Nishina, Toshinori Unno, Yoshitaka Uno, Takayuki Kubodera, Tadashi Kanouchi, Hidehiro Mizusawa and Takanori Yokota

Molecular Therapy 16: 557-564; doi:10.1038/sj.mt.6300382

Top
Titers of HIV-based Vectors Encoding shRNAs are Reduced by a Dicer-dependent Mechanism

Kazutaka Nishina, Toshinori Unno, Yoshitaka Uno, Takayuki Kubodera, Tadashi Kanouchi, Hidehiro Mizusawa and Takanori Yokota

Molecular Therapy 16: 378-386; doi:10.1038/sj.mt.6300370

Top

2007

Top
Specific inhibition of HBV replication in vitro and in vivo with expressed long hairpin RNA

Weinberg, M.S., Ely, A., Barichievy, S., Crowther, C., Mufamadi, S., Carmona, S., Arbuthnot, P.

Molecular Therapy 15: 534-541; doi:10.1038/sj.mt.6300077

Top
Combinatorial RNAi: A winning strategy for the race against evolving targets?

Grimm, D., Kay, M.A.

Molecular Therapy 15: 878-888; doi:10.1038/sj.mt.6300116

Top

2006

Top
Progress towards in vivo use of siRNAs

Behlke, M.A.

Molecular Therapy 13: 644-670; doi:10.1016/j.ymthe.2006.01.001

Top
Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo

Judge, A.D., Bola, G., Lee, A.C.H., MacLachlan, I.

Molecular Therapy 13: 494-505; 10.1016/j.ymthe.2005.11.002

Top
Silencing of HIV-1 with RNA Interference: a Multiple shRNA Approach

ter Brake, O., Konstantinova, P., Ceylan, M., Berkhout, B.

Molecular Therapy 14: 883-892; doi:10.1016/j.ymthe.2006.07.007

Top
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System

Howard, K.A., Rahbek, U.L., Liu, X., Damgaard,C.K., Glud, S.Z., Andersen,M.Ø, Hovgaard, M.B., Schmitz, A., Nyengaard, J.R., Besenbacher,F. and Kjems, J.

Molecular Therapy 14: 476-484; doi:10.1016/j.ymthe.2006.04.010

Top

Nature

Top
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

Mark E. Kleinman, Kiyoshi Yamada, Atsunobu Takeda, Vasu Chandrasekaran, Miho Nozaki, Judit Z. Baffi, Romulo J. C. Albuquerque, Satoshi Yamasaki, Masahiro Itaya, Yuzhen Pan, Binoy Appukuttan, Daniel Gibbs, Zhenglin Yang, Katalin Karikó, Balamurali K. Ambati, Traci A. Wilgus, Luisa A. DiPietro, Eiji Sakurai, Kang Zhang, Justine R. Smith, Ethan W. Taylor & Jayakrishna Ambati.

Nature 452: 591-597; doi:10.1038/nature06765

Top
Transvascular delivery of small interfering RNA to the central nervous system

John Witte

Nature 448: 39-43; doi:10.1038/nature05901

Top

Nature Medicine

Top
In vivo imaging of siRNA delivery and silencing in tumors

Zdravka Medarova, Wellington Pham, Christian Farrar, Victoria Petkova, Anna Moore

Nature Medicine 13: 372 - 377; doi:10.1038/nm1486

Top

Nature Reviews Genetics

Top
Strategies for silencing human disease using RNA interference

Daniel H. Kim, John J. Rossi

Nature Reviews Genetics 8: 173-184; doi:10.1038/nrg2006

Top
Genetic medicines: treatment strategies for hereditary disorders

Stuart J. Ellem and Gail P. Risbridger

Nature Reviews Genetics 7: 261-276; doi:10.1038/nrg1829

Top

Nature Reviews Drug Discovery

Top
Interfering with disease: a progress report on siRNA-based therapeutics

Antonin de Fougerolles, Hans-Peter Vornlocher, John Maraganore & Judy Lieberman

Nature Reviews Drug Discovery 6: 443-453; doi:10.1038/nrd2310

Top

Nature Chemical Biology

Top
RNAi therapeutics: a potential new class of pharmaceutical drugs

David Bumcrot, Muthiah Manoharan, Victor Koteliansky and Dinah W Y Sah

Nature Chemical Biology 2: 711-719; doi:10.1038/nchembio839

Top

Nature Reviews Molecular Cell Biology

Top
Illuminating the silence: understanding the structure and function of small RNAs

Tariq M. Rana

Nature Reviews Molecular Cell Biology 8: 23-36; doi:10.1038/nrm2085

Top

Nature Clinical Practice Neurology

Top
Technology Insight: therapeutic RNA interference-how far from the neurology clinic?

Pedro Gonzalez-Alegre and Henry L Paulson

Nature Clinical Practice Neurology 3: 394-404; doi:10.1038/ncpneuro0551

Top

Laboratory Investigation

Top
In vivo post-transcriptional gene silencing of a-1 antitrypsin by adeno-associated virus vectors expressing siRNA

Pedro E Cruz, Christian Mueller, Travis L Cossette, Alexandra Golant, Qiushi Tang, Stuart G Beattie, Mark Brantly, Martha Campbell-Thompson, Keith S Blomenkamp, Jeffrey H Teckman and Terence R Flotte

Laboratory Investigation 87: 893-902; doi:10.1038/labinvest.3700629

Top
Everything you wanted to know about small RNA but were afraid to ask

Scott D Boyd

Laboratory Investigation 88; 569-578; doi: 10.1038/labinvest.2008.32

Top

British Journal of Cancer

Top
Enhancement of radiation response by inhibition of Aurora-A kinase using siRNA or a selective Aurora kinase inhibitor PHA680632 in p53-deficient cancer cells

Lecluse Y, Auperin A, Bourhis J, Deutsch E

British Journal of Cancer 97: 1664-1672; doi:10.1038/sj.bjc.6604083

Top
RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells

Strillacci A, Griffoni C, Spisni E, Manara MC, Tomasi V

British Journal of Cancer 94: 1300-1310; doi:10.1038/sj.bjc.6603094

Top

British Journal of Pharmacology

Top
Investigation of the role of TASK-2 channels in rat pulmonary arteries; pharmacological and functional studies following RNA interference procedures

Gonczi M, Szentandrassy N, Johnson IT, Heagerty AM, Weston AH

British Journal of Pharmacology 147: 496-505; doi:10.1038/sj.bjp.0706649

Top

Clinical Pharmacology & Therapeutics

Top
Commentary: 'Drug Discovery and Development in the Age of Molecular Medicine'

P Vallance and M Levick

Clinical Pharmacology & Therapeutics 82: 363-366; doi:10.1038/sj.clpt.610033

Top

Cancer Gene Therapy

Top
siRNA-based approaches in cancer therapy

G R Devi

Cancer Gene Therapy 13: 819-829 ; doi:10.1038/sj.cgt.7700931

Top
New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer

K Yamato, T Yamada, M Kizaki, K Ui-Tei, Y Natori, M Fujino, T Nishihara, Y Ikeda, Y Nasu, K Saigo, M Yoshinouchi

Cancer Gene Therapy 15: 140-153; doi:10.1038/sj.cgt.7701118

Top

Gene Therapy

Top
Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass

Kinouchi N, Ohsawa Y, Ishimaru N, Ohuchi H, Sunada Y, Hayashi Y, Tanimoto Y, Moriyama K, Noji S

Gene Therapy advance online publication; doi:10.1038/gt.2008.24

Top
Increased virus replication in mammalian cells by blocking intracellular innate defense responses

de Vries W, Haasnoot J, van der Velden J, van Montfort T, Zorgdrager F, Paxton W, Cornelissen M, van Kuppeveld F, de Haan P, Berkhout B.

Gene Therapy 15: 545-52; doi:10.1038/gt.2008.12

Top

Journal of Investigative Dermatology

Top
Development of Therapeutic siRNAs for Pachyonychia Congenita

Frances J D Smith, Robyn P Hickerson, Jane M Sayers, Robert E Reeves, Christopher H Contag, Devin Leake, Roger L Kaspar and W H Irwin McLean

Journal of Investigative Dermatology 128: 50-58; doi:10.1038/sj.jid.5701040

Top
Delivery and Inhibition of Reporter Genes by Small Interfering RNAs in a Mouse Skin Model

Qian Wang, Heini Ilves, Pauline Chu, Christopher H Contag, Devin Leake, Brian H Johnston and Roger L Kaspar

Journal of Investigative Dermatology 127: 2577-2584; doi:10.1038/sj.jid.5700891

Extra navigation

.

naturejobs

ADVERTISEMENT